DXCM Q2 2025 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.2B+15.2% YoY

Gross Profit

$689M59.5% margin

Operating Income

$213M18.4% margin

Net Income

$180M15.5% margin

EPS (Diluted)

$0.45

QoQ Revenue Growth

+11.7%

Cash Flow

Operating Cash Flow

$303M

Free Cash Flow

$209M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$7.3B

Total Liabilities

$4.8B

Stockholders' Equity

$2.6B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.0B	+15.2%
Gross Profit	$689M	$627M	+9.9%
Operating Income	$213M	$158M	+34.6%
Net Income	$180M	$144M	+25.3%

Geographic Segments

UNITED STATES

$841M73%

Non-US

$316M27%